clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Separate Studies Show Why Some Prostate Cancers Become Resistant to Hormone…
Informatics
Generative AI Experts Absci Partner with AstraZeneca to Develop Cancer Treatment
News & Features
In Big Obesity Move, Roche Acquires Carmot Therapeutics for $2.7B Up…
News & Features
AbbVie Buys ImmunoGen for $10.1B to Speed Entry into Ovarian Cancer…
News & Features
Biological Robots Show Healing Potential
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Rapid diagnostic test
Molecular Dx
Tear Drop Test Is First Rapid, Point-of-Care Diagnostic for Parkinson’s Disease
Chris Anderson
-
September 13, 2023
0
Coronavirus
New COVID-19 Testing Method Can Potentially Catch Infections Just Hours after Exposure
Chris Anderson
-
February 28, 2023
0
Coronavirus
Hong Kong Data Reveals Current COVID Vaccines Protect against Omicron, Briefly
Malorye Branca
-
February 15, 2023
0
Molecular Dx
Talis Wins Up-to-$8.6M from CARB-X to Develop MDx for Infectious Diseases
Clinical OMICs Staff Writer
-
May 11, 2018
0
Related Content
Smartwatch Data Plus Digital Twin Framework Predicts Risk of Heart Disease and Heart Attack
Merck Snaps Up Parkinson’s Candidates For Up to $610M
Coffee Extract Plus Quantum Dot Technology Could Stop Neurodegenerative Disease
Protein Allows Production of Norepinephrine Neurons from Stem Cells, with Implications for Alzheimer’s and Parkinson’s Research
Inside Precision Medicine
![Talis Biomedical has won up to $8.6 million in CARB-X funding toward developing pathogen identification and antibiotic susceptibility molecular diagnostics for chlamydia and gonorrhea. [CDC]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1673-768x432.jpeg "Talis Wins Up-to-$8.6M from CARB-X to Develop MDx for Infectious Diseases")
